BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Lowe P, Krivoy A, Porffy L, Henriksdottir E, Eromona W, Shergill SS. When the drugs don't work: treatment-resistant schizophrenia, serotonin and serendipity. Ther Adv Psychopharmacol 2018;8:63-70. [PMID: 29344345 DOI: 10.1177/2045125317737003] [Cited by in Crossref: 8] [Cited by in F6Publishing: 7] [Article Influence: 1.6] [Reference Citation Analysis]
Number Citing Articles
1 Papanastasiou E, Mouchlianitis E, Joyce DW, McGuire P, Banaschewski T, Bokde ALW, Bromberg U, Büchel C, Quinlan EB, Desrivières S, Flor H, Frouin V, Garavan H, Spechler P, Gowland P, Heinz A, Ittermann B, Martinot JL, Paillère Martinot ML, Artiges E, Nees F, Papadopoulos Orfanos D, Poustka L, Millenet S, Fröhner JH, Smolka MN, Walter H, Whelan R, Schumann G, Shergill S; IMAGEN Consortium. Examination of the Neural Basis of Psychoticlike Experiences in Adolescence During Reward Processing. JAMA Psychiatry 2018;75:1043-51. [PMID: 30073329 DOI: 10.1001/jamapsychiatry.2018.1973] [Cited by in Crossref: 16] [Cited by in F6Publishing: 11] [Article Influence: 5.3] [Reference Citation Analysis]
2 Thomas M, Szentgyorgyi T, Vanes LD, Mouchlianitis E, Barry EF, Patel K, Wong K, Joyce D, Shergill S. Cognitive performance in early, treatment-resistant psychosis patients: Could cognitive control play a role in persistent symptoms? Psychiatry Res 2021;295:113607. [PMID: 33285345 DOI: 10.1016/j.psychres.2020.113607] [Reference Citation Analysis]
3 Rodriguez V, Hanley K, Arias AJ, Quattrone D, Kuforiji J, Whiskey E, Shergill SS. Successful clozapine rechallenge following recurrent clozapine-associated pancreatitis: a case report. BMC Pharmacol Toxicol 2020;21:35. [PMID: 32434548 DOI: 10.1186/s40360-020-00413-6] [Cited by in Crossref: 1] [Article Influence: 0.5] [Reference Citation Analysis]
4 Velligan DI, Brain C, Bouérat Duvold L, Agid O. Caregiver Burdens Associated With Treatment-Resistant Schizophrenia: A Quantitative Caregiver Survey of Experiences, Attitudes, and Perceptions. Front Psychiatry 2019;10:584. [PMID: 31551821 DOI: 10.3389/fpsyt.2019.00584] [Cited by in Crossref: 7] [Cited by in F6Publishing: 9] [Article Influence: 2.3] [Reference Citation Analysis]
5 Han S, Cui Q, Guo X, Fan YS, Guo J, Zong X, Hu M, Lu F, Chen X, Chen H. Disconnectivity between the raphe nucleus and subcortical dopamine-related regions contributes altered salience network in schizophrenia. Schizophr Res 2020;216:382-8. [PMID: 31801675 DOI: 10.1016/j.schres.2019.11.006] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 1.3] [Reference Citation Analysis]
6 Horne CM, Vanes LD, Verneuil T, Mouchlianitis E, Szentgyorgyi T, Averbeck B, Leech R, Moran RJ, Shergill SS. Cognitive control network connectivity differentially disrupted in treatment resistant schizophrenia. Neuroimage Clin 2021;30:102631. [PMID: 33799270 DOI: 10.1016/j.nicl.2021.102631] [Reference Citation Analysis]
7 Rodríguez B, Nani JV, Almeida PGC, Brietzke E, Lee RS, Hayashi MAF. Neuropeptides and oligopeptidases in schizophrenia. Neurosci Biobehav Rev 2020;108:679-93. [PMID: 31794779 DOI: 10.1016/j.neubiorev.2019.11.024] [Cited by in Crossref: 8] [Cited by in F6Publishing: 6] [Article Influence: 2.7] [Reference Citation Analysis]